HDII - Hypertension Diagnostics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/20126/30/20116/30/20106/30/2009
Total Revenue3,157.747-1,383.669503.175
Cost of Revenue3,269.601--17.06130.004
Gross Profit-111.854-1,400.729373.171
Operating Expenses
Research Development----
Selling General and Administrative1,186.51326.9312,397.507626.272
Non Recurring----
Others53.57731.47431.47431.474
Total Operating Expenses4,514.013360.9322,382.838764.759
Operating Income or Loss-1,356.266-360.932-999.169-261.584
Income from Continuing Operations
Total Other Income/Expenses Net-116.0655.8569.4113.144
Earnings Before Interest and Taxes-1,356.266-360.932-999.169-261.584
Interest Expense-143.565-143.565-143.565-143.565
Income Before Tax-1,472.331-355.076-989.759-248.44
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-1,472.331-355.076-989.759-248.44
Non-recurring Events
Discontinued Operations209.084761.388761.388761.388
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-1,263.247406.312-989.759-248.44
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-1,263.247406.312-989.759-248.44